Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2006 Feb;20(2):163-5.
doi: 10.1038/sj.eye.6701828.

Resolution of severe macular oedema in adult Coat's syndrome with high-dose intravitreal triamcinolone acetonide

R R Jarin  1 , S C B Teoh, T H Lim
Affiliations
Case Reports

Resolution of severe macular oedema in adult Coat's syndrome with high-dose intravitreal triamcinolone acetonide

R R Jarin et al. Eye (Lond). 2006 Feb.

Abstract

Objective: To report the clinical outcome of a patient who received high-dose intravitreal triamcinolone acetonide as treatment for severe macular oedema secondary to adult Coat's syndrome.

Method: Case report.

Results: A 74-year-old Indian man complaining of chronic gradual blurring of vision in the left eye was found to have adult Coat's syndrome with severe macular oedema. He received 25 mg of intravitreal triamcinolone acetonide following unsuccessful resolution with grid laser. Optical coherence tomography (OCT) demonstrated up to 75% decrease in macular oedema that was evident even after 9 months follow-up. However, there was no significant improvement in visual acuity.

Conclusion: Intravitreal triamcinolone is a reasonable option in reducing severe macular oedema in cases of adult Coat's syndrome.

PubMed Disclaimer

Publication types

LinkOut - more resources